Post by Novotech

Ahead of BIO 2026, many biotech and pharma companies are evaluating how best to balance timelines, study execution, patient access, and regional strategy in global clinical trials. Novotech will be in San Diego, June 22–25, meeting with sponsors advancing development programs across global markets Request a meeting with our leadership team and global experts: https://lnkd.in/gJQiFuCy or contact us via the partnership platforms: BIO Partnering™ https://lnkd.in/ghn8Cfns RESI Partnering https://lnkd.in/g62PMikU #BIO2026 #ClinicalTrials